Changes in Coagulation Parameters and Metabolic Profile in Hospitalized Patients with Metabolic Dysfunction-Associated Steatohepatitis Receiving Vitamin K: A Retrospective Observational Study
Open Access
- 21 May 2026
- journal article
- research article
- Published by MDPI AG in Clinics and Practice
- Vol. 16 (5) , 97
Abstract
Background/Objectives: Metabolic dysfunction-associated steatohepatitis (MASH) is frequently accompanied by disturbances in coagulation and metabolic homeostasis, partly related to impaired handling of vitamin K-dependent pathways. Although vitamin K is often administered to correct abnormal coagulation tests, its biochemical impact in hospitalized patients with MASH remains insufficiently characterized. This study aimed to evaluate changes in coagulation and metabolic parameters in hospitalized patients with MASH receiving vitamin K supplementation. Methods: We conducted a retrospective study of 84 hospitalized MASH patients who received vitamin K supplementation. Biochemical parameters were recorded at admission and discharge to assess short-term changes during hospitalization. Results: Vitamin K supplementation was associated with modest changes in coagulation parameters, including reductions in PT, INR, and aPTT (e.g., PT decreased from 13.00 s to 11.00 s). Small numerical changes in transaminases, fasting glucose, and total cholesterol were observed during hospitalization, with limited clinical relevance. These patterns were comparable across fibrosis stages, with no significant differences between groups. Discussion: The observed biochemical findings are likely in-hospital factors rather than a direct metabolic effect of vitamin K. Conclusions: Vitamin K supplementation was associated with modest changes in coagulation parameters and small, clinically negligible variations in selected metabolic markers in patients with MASH, irrespective of fibrosis stage. These findings suggest a supportive biochemical effect in selected contexts; further prospective studies are needed to clarify their clinical relevance.Keywords
This publication has 35 references indexed in Scilit:
- Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patientsScientific Reports, 2025
- Dietary macro and micronutrients associated with MASLD: Analysis of a national US cohort databaseAnnals of Hepatology, 2024
- Vitamin K2 protects mice against non-alcoholic fatty liver disease induced by high-fat dietScientific Reports, 2024
- The effect of vitamin K4 supplementation on insulin resistance in individuals with type 2 diabetes: a double-blind randomised placebo-controlled clinical trialEuropean Journal of Nutrition, 2023
- Changing epidemiology, global trends and implications for outcomes of NAFLDJournal of Hepatology, 2023
- The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic reviewHepatology, 2023
- Non-alcoholic fatty liver diseaseThe Lancet, 2021
- EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosisJournal of Hepatology, 2018
- Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivationJournal of Hepatology, 2015
- Vitamin K and Vitamin D Status: Associations with Inflammatory Markers in the Framingham Offspring StudyAmerican Journal of Epidemiology, 2007